Story thread · 9 reports / 8 sources
AstraZeneca's $5bn drug promise is no 'buy' signal for Deutsche
finance.yahoo.com · 4d
How the coverage leans
Across 8 sources · syndicated copies counted once
First report: STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies — statnews.com, 6d
The coverage
- COPD and Heart Disease Demand Integrated Clinical Care
medscape.com · 5d
- IL-33 Inhibitor Delivers in COPD Trials
medpagetoday.com · 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.